Darifenacin hydrobromide

Darifenacin hydro­bromide

In the title compound {systematic name: (S)-3-[(aminocar-bonyl)diphenylmethyl]-1-[2-(2,3-di-hy-dro-benzofuran-5-yl)ethyl]pyrrolidinium bromide}, C(28)H(31)N(2)O(2) (+)·Br(-), the pyrrolidine rings adopts an envelope conformation. The two phenyl rings make a dihedral angle of 72.5 (1)°. The four coplanar atoms of the pyrrolidine ring makes dihedral angles of 33.1 (2) and 82.8 (2)° with the two p...

Polymorphic Study of (-)-galanthamine Hydrobromide

Preparation of Arsenobetaine hydrobromide

Crystalline arsenobetaine hydrobromide is deposited directly on addition of trimethylarsine to a benzene solution of bromoacetic acid. The product is stable, non-deliquescent and may be readily converted into the free betaine by passage through basic ion exchange resin.

Antioxidant properties of galantamine hydrobromide.

The antioxidant properties of galantamine hydrobromide ((4alpha,6beta)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide) were studied in vitro, using luminol-dependent chemiluminescence and spectrophotometry. It was found that this compound was a scavenger of reactive oxygen species (ROS). By comparing the antioxidant effects of galantamine ((...

Hydroquinine hydrobromide and hypoglycaemia Introduction

Introduction Hydroquinine hydrobromide (Inhibin) has been approved for marketing in the Netherlands for the treatment of nocturnal cramps when treatment with drugs is considered necessary. It is available in the Netherlands since March 1990 as an over-the-counter drug with a dose of 200 mg with the evening meal and a further 100 mg at bedtime for 14 days. According to the Summary of Product Cha...